TW201907943A - A use of an extract of Bombax malabaricum DC - Google Patents
A use of an extract of Bombax malabaricum DC Download PDFInfo
- Publication number
- TW201907943A TW201907943A TW106123477A TW106123477A TW201907943A TW 201907943 A TW201907943 A TW 201907943A TW 106123477 A TW106123477 A TW 106123477A TW 106123477 A TW106123477 A TW 106123477A TW 201907943 A TW201907943 A TW 201907943A
- Authority
- TW
- Taiwan
- Prior art keywords
- kapok
- extract
- aqueous extract
- liver
- water
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Abstract
Description
本發明係關於一種木棉花水萃物的用途,特別關於一種木棉花水萃物應用於製備防治化學性肝損傷的藥物的用途。 The invention relates to the use of an aqueous extract of kapok, in particular to the use of an aqueous extract of kapok in the preparation of a medicament for preventing and treating chemical liver injury.
肝臟為人體中以代謝功能為主的器官,並扮演去除毒素的角色。當人體接觸化學毒素時,化學毒素會被運送到肝臟以進行代謝,然而大量的化學毒素的累積卻會造成化學性肝損傷,而使人體出現急性肝炎(acute hepatitis)甚或猛爆性肝炎(fulminant hepatitis)等症狀。 The liver is a metabolically active organ in the human body and plays a role in removing toxins. When the human body is exposed to chemical toxins, chemical toxins are transported to the liver for metabolism. However, the accumulation of a large amount of chemical toxins causes chemical liver damage, which causes acute hepatitis or even fulminant. Hepatitis) and other symptoms.
猛爆性肝炎係指肝功能突然的嚴重喪失,目前認定以肝臟移植為最佳的治療方法,惟捐贈之肝臟取得不易,且手術後常見合併禁忌症,因此仍以防治化學性肝損傷,進而避免猛爆性肝炎的發生為第一手段。 Severe hepatitis refers to a sudden and severe loss of liver function. It is currently considered to be the best treatment for liver transplantation. However, the donated liver is not easy to obtain, and common contraindications after surgery are common. Therefore, chemical liver injury is still prevented. Avoid the occurrence of violent hepatitis as the first means.
為解決上述問題,本發明提供一種木棉花水萃物的用途,係將萃取自木棉花之活性成分,應用於製備防治化學性肝損傷的藥物者。 In order to solve the above problems, the present invention provides a use of an aqueous extract of kapok, which is applied to a medicament for preparing a chemical liver injury by extracting an active ingredient extracted from kapok.
本發明之木棉花水萃物的用途,係應用於製備防治化學性肝損傷的藥物,其中,該木棉花水萃物係以水於115~125℃之溫度、0.35~0.5Kg/cm2G之壓力下萃取1.5~3小時所獲得,較佳地,該木棉花水萃物係能夠以口服方式投予一所需個體,且該木棉花水萃物之每天投予該所需個體之劑量為2~6毫升/公斤體重;如此藉由萃取自木棉花之活性成分,可以降低四氯化碳所造成之肝功能指數升高的現象及減緩四氯化碳所造成之肝細胞壞死的現象,因而可以應用於製備防治化學性肝損傷的藥物,為 本發明之功效。 The use of the kapok aqueous extract of the invention is applied to the preparation of a medicament for preventing and treating chemical liver injury, wherein the kapok aqueous extract is at a temperature of 115 to 125 ° C, 0.35 to 0.5 Kg/cm 2 G. The extraction is carried out under pressure for 1.5 to 3 hours. Preferably, the kapok aqueous extract can be administered orally to a desired individual, and the kapok aqueous extract is administered to the desired individual daily. It is 2~6ml/kg body weight; thus, by extracting the active ingredients from kapok, it can reduce the increase of liver function index caused by carbon tetrachloride and slow down the necrosis of liver cells caused by carbon tetrachloride. Therefore, it can be applied to the preparation of a medicament for preventing and treating chemical liver damage, which is an effect of the present invention.
第1a圖:試驗(A)中,投予本發明木棉花水萃物對肝功能指數GOT/AST的影響結果。 Figure 1a: Results of the effect of the aqueous extract of Kapok according to the invention on liver function index GOT/AST in test (A).
第1b圖:試驗(A)中,投予本發明木棉花水萃物對肝功能指數GPT/ALT的影響結果。 Figure 1b: Test (A), the effect of the extract of the Kapok extract of the present invention on the liver function index GPT/ALT.
第2a~2d圖:試驗(B)中,投予本發明木棉花水萃物對肝細胞壞死的影響結果。 2a~2d: In the test (B), the effect of the aqueous extract of the kapok of the present invention on hepatocyte necrosis was administered.
為讓本發明之上述及其他目的、特徵及優點能更明顯易懂,下文特舉本發明之較佳實施例,並配合所附圖式,作詳細說明如下: The above and other objects, features and advantages of the present invention will become more <RTIgt;
本發明所述之「木棉(Bombax malabaricum DC.)」,係指木棉科(Bombacaceae)木棉屬(malabaricum)的植物,其花朵(即,木棉花)清熱解毒,常被用於煲湯。 "Kapok (Bombax malabaricum DC.)" Of the present invention, means Bombacaceae (Bombacaceae) bombax (malabaricum) of the plant, its flowers (ie, Kapok) detoxification, often used in soup.
本發明之木棉花水萃物,係可以降低四氯化碳所造成之肝功能指數升高的現象及減緩四氯化碳所造成之肝細胞壞死的現象,因而可以應用於製備防治化學性肝損傷的藥物,該木棉花水萃物與醫藥學上可以接受之載劑或賦形劑組合形成一醫藥組合物,其中,該木棉花水萃物係可以製備成任何方便食用之型式,如錠劑、膠囊、粉劑、粒劑或液劑等,或者將該木棉花水萃物與其他食品或飲料組合,以適於食用之樣態供生物體以口服方式服用。 The kapok water extract of the invention can reduce the liver function index caused by carbon tetrachloride and slow down the hepatocyte necrosis caused by carbon tetrachloride, so it can be applied to prepare chemical liver The damaged drug, the kapok aqueous extract is combined with a pharmaceutically acceptable carrier or excipient to form a pharmaceutical composition, wherein the kapok aqueous extract can be prepared into any convenient form, such as an ingot. The agent, the capsule, the powder, the granule or the liquid agent, or the like, or the kapok water extract is combined with other foods or beverages, and is suitable for eating for the organism to be taken orally.
又,本發明之木棉花水萃物係可以供投予一所需個體,例如以2~6毫升/公斤體重之劑量投予該所需個體,使該木棉花水萃物係所含有之活性成分得以於該所需個體體內作用,而可以降低四氯化碳所造成之 肝功能指數升高的現象及減緩四氯化碳所造成之肝細胞壞死的現象。 Further, the kapok aqueous extract of the present invention can be administered to a desired individual, for example, by administering the desired individual at a dose of 2 to 6 ml/kg of body weight to impart activity to the kapok aqueous extract. The component can act in the desired individual, and can reduce the increase of liver function index caused by carbon tetrachloride and slow down the hepatocyte necrosis caused by carbon tetrachloride.
其中,該木棉花水萃物較佳係可以藉由一包含以下步驟之方法所製得:提供一木棉花樣品;以水作為一萃取溶劑萃取該木棉花樣品,得一木棉花粗萃液;及將該木棉花粗萃液進行濃縮,以獲得該木棉花水萃物。 Wherein, the kapok aqueous extract is preferably obtained by a method comprising the steps of: providing a kapok sample; extracting the kapok sample with water as an extraction solvent to obtain a kapok crude extract; And concentrating the kapok crude extract to obtain the kapok aqueous extract.
詳而言之,係可以預先將該木棉花樣品於110~120℃之溫度下進行乾燥(將100克木棉花樣品乾燥至20克),得到一木棉花乾燥物;此外,該木棉花樣品亦可以預先碎成粉粒(粒徑約為1~2mm),以增加該木棉花樣品與該萃取溶劑之接觸表面積,藉此提升後續萃取之萃取效率。 In detail, the kapok sample may be preliminarily dried at a temperature of 110 to 120 ° C (100 g of the kapok sample is dried to 20 g) to obtain a kapok dried product; in addition, the kapok sample is also It can be preliminarily broken into powder particles (having a particle size of about 1 to 2 mm) to increase the contact surface area of the kapok sample with the extraction solvent, thereby improving the extraction efficiency of the subsequent extraction.
舉例而言,每4.8公斤之木棉花樣品係能夠混合該萃取溶劑,使二者總體積達80公升,並於115~125℃之溫度、0.35~0.5Kg/cm2G之壓力下進行萃取1.5~3小時,上述萃取亦可以重複數次,使該木棉花樣品所富含之活性成分可以完整溶出於該萃取溶劑,此為本發明所屬技術領域中具有通常知識者所廣泛應用,在此不加以贅述。 For example, each 4.8 kg of kapok sample can be mixed with the extraction solvent to a total volume of 80 liters, and extracted at a temperature of 115 to 125 ° C and a pressure of 0.35 to 0.5 Kg/cm 2 G. ~3 hours, the above extraction may also be repeated several times, so that the active ingredient rich in the kapok sample can be completely dissolved in the extraction solvent, which is widely used by those having ordinary knowledge in the technical field of the invention. Repeat them.
前述之木棉花粗萃液可以經過減壓濃縮及冷凍乾燥,以獲得該木棉花水萃物,藉由此一程序,係可以使該木棉花水萃物之活性成分更加濃縮,是以僅需使用少量之該木棉花水萃物即可以發揮最佳療效。 The aforementioned kapok crude extract can be concentrated under reduced pressure and freeze-dried to obtain the kapok aqueous extract. By this procedure, the active constituents of the kapok aqueous extract can be more concentrated, so that only The best effect can be achieved by using a small amount of this kapok water extract.
為證實本發明之木棉花水萃物係可以降低四氯化碳所造成之肝功能指數升高的現象及減緩四氯化碳所造成之肝細胞壞死的現象,遂將每4.8公斤之木棉花樣品萃取所得之木棉花粗萃液,經過減壓濃縮及冷凍乾燥獲得共800克之木棉花水萃物粉末,另將5克之木棉花水萃物粉末溶於20毫升之水後,進行以下試驗。 In order to confirm that the Kapok water extract system of the present invention can reduce the liver function index caused by carbon tetrachloride and slow down the hepatocyte necrosis caused by carbon tetrachloride, the 4.8 kg of kapok will be used. The crude kapok extract obtained by the sample extraction was concentrated under reduced pressure and freeze-dried to obtain a total of 800 g of the kapok aqueous extract powder, and after 5 g of the kapok aqueous extract powder was dissolved in 20 ml of water, the following test was carried out.
(A)木棉花水萃物對肝功能指數的影響 (A) Effect of Kapok Water Extract on Liver Function Index
本試驗係選用雄性Wistar大鼠(200~250g)進行試驗,分別以如第1表所示之木棉花水萃物連續經口灌食各組大鼠4天(每天一 次),於第4天以腹腔注射四氯化碳(溶於橄欖油中,濃度為20%),24小時候犧牲各組大鼠,經心臟採血取得血清,以分析各組大鼠的肝功能指數,其結果如第1a、1b圖所示。 In this test, male Wistar rats (200-250 g) were used for the test, and the rats of each group were continuously orally administered with the extract of Kapok as shown in Table 1 for 4 days (once a day), on the fourth day. The rats were intraperitoneally injected with carbon tetrachloride (dissolved in olive oil at a concentration of 20%). At 24 hours, rats in each group were sacrificed, and blood was collected by cardiac blood sampling to analyze the liver function index of each group. The results are as shown in 1a. , Figure 1b.
請參照第1a、1b圖所示,濃度為2~6mL/kg的木棉花水萃物可以有效降低四氯化碳所造成之肝功能指數上升的問題(第A2、A3組)。 Please refer to the figures 1a and 1b. The water extract of Kapok with a concentration of 2~6mL/kg can effectively reduce the increase of liver function index caused by carbon tetrachloride (Groups A2 and A3).
(B)木棉花水萃物對壞死之肝細胞的影響 (B) Effect of Kapok aqueous extract on necrotic hepatocytes
本試驗同樣選用雄性Wistar大鼠進行試驗,分別以如第2表所示之木棉花水萃物連續經口灌食各組大鼠4天(每天一次),於第4天以腹腔注射四氯化碳(溶於橄欖油中,濃度為20%),24小時候犧牲各組大鼠,收取肝臟後,切片並進行蘇木素一伊紅染色(hematoxylin and eosin stain、H&E stain),結果分別如第2a~2d圖所示。 In this experiment, male Wistar rats were also used for the test. The rats were continuously orally administered with the extract of Kapok as shown in Table 2 for 4 days (once a day), and intraperitoneal injection of tetrachlorochloride on the 4th day. Carbon (dissolved in olive oil, concentration 20%), sacrificed rats in 24 hours, collected liver, sliced and hematoxylin and eosin stain, H&E stain, the results are as follows Figure 2a~2d shows.
請參照第2b圖所示,經四氯化碳處理之第B1組大鼠之肝臟 的中央靜脈(Central Venous,簡稱CV)附近肝細胞壞死,整體組織結構紊亂;而預先經口灌食濃度為2~6mL/kg的木棉花水萃物之第B2、B3組大鼠之中央靜脈附近肝細胞壞死的現象則有減緩的狀況,顯示本發明之木棉花水萃物可以有效減緩四氯化碳所造成之肝細胞壞死的現象。 Please refer to Figure 2b for the hepatocyte necrosis near the central vein (CV) of the liver of the B1 group of rats treated with carbon tetrachloride, and the overall tissue structure is disordered; The phenomenon of hepatocyte necrosis near the central vein of rats in the B2 and B3 groups of 2-6 mL/kg of Kapok water extract was slowed, indicating that the Kapok water extract of the present invention can effectively alleviate carbon tetrachloride. The phenomenon of hepatocyte necrosis caused.
綜合上述,本發明之木棉花水萃物的用途係藉由萃取自木棉花之活性成分,可以降低四氯化碳所造成之肝功能指數升高的現象及減緩四氯化碳所造成之肝細胞壞死的現象,因而可以應用於製備防治化學性肝損傷的藥物,為本發明之功效。 In summary, the use of the kapok aqueous extract of the present invention can reduce the increase in liver function index caused by carbon tetrachloride and slow down the liver caused by carbon tetrachloride by extracting the active ingredient from kapok. The phenomenon of cell necrosis can be applied to the preparation of a drug for preventing and treating chemical liver damage, which is an effect of the present invention.
雖然本發明已利用上述較佳實施例揭示,然其並非用以限定本發明,任何熟習此技藝者在不脫離本發明之精神和範圍之內,相對上述實施例進行各種更動與修改仍屬本發明所保護之技術範疇,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 While the invention has been described in connection with the preferred embodiments described above, it is not intended to limit the scope of the invention. The technical scope of the invention is protected, and therefore the scope of the invention is defined by the scope of the appended claims.
Claims (3)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW106123477A TW201907943A (en) | 2017-07-13 | 2017-07-13 | A use of an extract of Bombax malabaricum DC |
CN201810766787.0A CN109248182A (en) | 2017-07-13 | 2018-07-12 | Application of kapok water extract |
PCT/US2018/041747 WO2019014411A1 (en) | 2017-07-13 | 2018-07-12 | Method for protecting against chemical-induced hepatotoxicity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW106123477A TW201907943A (en) | 2017-07-13 | 2017-07-13 | A use of an extract of Bombax malabaricum DC |
Publications (1)
Publication Number | Publication Date |
---|---|
TW201907943A true TW201907943A (en) | 2019-03-01 |
Family
ID=65001811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW106123477A TW201907943A (en) | 2017-07-13 | 2017-07-13 | A use of an extract of Bombax malabaricum DC |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN109248182A (en) |
TW (1) | TW201907943A (en) |
WO (1) | WO2019014411A1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104920727A (en) * | 2015-06-26 | 2015-09-23 | 王魁兴 | Jiejiu Hugan health tea and making method thereof |
TWI583389B (en) * | 2016-11-15 | 2017-05-21 | 景鑫生物科技有限公司 | A use of an extract of bombax malabaricum dc. |
CN106474417A (en) * | 2016-12-14 | 2017-03-08 | 曹晓宏 | A kind of Chinese medicine composition of Dealcoholic sobering-up and its preparation method and application |
-
2017
- 2017-07-13 TW TW106123477A patent/TW201907943A/en unknown
-
2018
- 2018-07-12 WO PCT/US2018/041747 patent/WO2019014411A1/en active Application Filing
- 2018-07-12 CN CN201810766787.0A patent/CN109248182A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2019014411A1 (en) | 2019-01-17 |
CN109248182A (en) | 2019-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI583389B (en) | A use of an extract of bombax malabaricum dc. | |
TWI595881B (en) | A use of an extract of asplenium australasicum (j. sm.) hook. | |
TWI612967B (en) | A use of an extract of asplenium australasicum (j. sm.) hook. | |
US10953060B2 (en) | Method for extraction of Chinese herbal medicine using small molecule micro-shear technology | |
CN102283859B (en) | Application of dicliptera chinensis polysaccharide | |
CN102188519B (en) | Chinese medicinal compound preparation for treating hepatic fibrosis and preparation method thereof | |
TW201907943A (en) | A use of an extract of Bombax malabaricum DC | |
TWI615146B (en) | A use of an extract of asplenium australasicum (j. sm.) hook. | |
TWI612968B (en) | A use of an extract of asplenium australasicum (j. sm.) hook. | |
TWI605821B (en) | A use of an extract of asplenium australasicum (j. sm.) hook. | |
CN109512847B (en) | Application of plumbagin in preparing medicine for treating pulmonary fibrosis diseases | |
US9272010B2 (en) | Herbal extract and a method of treating liver cancer | |
CN109939200B (en) | Traditional Chinese medicine composition and application thereof in preparation of medicine for treating acute kidney injury | |
CN106074662A (en) | A kind of Rhizoma Curcumae Longae compositions with effects of relieving alcoholism and protecting liver | |
TWI594760B (en) | A use of an extract of bombax malabaricum dc. | |
TWI624264B (en) | A use of an extract of asplenium australasicum (j. sm.) hook. | |
TWI654985B (en) | A use of an extract of a formula including a fruit body of antrodia cinnamomea in the manufacture of a medicament for the treatment of hepatitis b | |
CN110201014A (en) | A kind of preparation method and applications of Panax stipuleanatus Tsai et Feng total saposins | |
EP4059509A1 (en) | Agrimonia eupatoria extract preparation method, and composition for improving liver functions or treating liver diseases, containing extract | |
CN106334018B (en) | Traditional Chinese medicine composition for treating hepatocellular carcinoma and application thereof | |
TW201818951A (en) | A use of an extract of Asplenium australasicum (J. Sm.) Hook | |
CN115286721A (en) | Active polysaccharide, active polysaccharide composition and application of active polysaccharide composition in preparation of product with effect of preventing or treating gastric injury | |
CN113440553A (en) | Cistanche deserticola composition for repairing chemical liver injury and preparation method thereof | |
CN104997818A (en) | Application of total saponins of helleborus thibetanus franch in preparing drugs for preventing and treating liver injuries | |
CN104873566A (en) | Pharmaceutical composition with antihepatitis activity and application of pharmaceutical composition |